Today’s Tech Tip
March 26, 2015
USA 111, Inc Tip Segment 1
Today’s tech tip is brought to you by tech expert, Elizabeth Little, from iRULU and The Balancing Act’s Julie Moran. Tablets are all the rage in technology today, but the purchase of one can leave a dent in your wallet. iRulu though has come to the rescue bringing savvy shoppers the eXpro X1 to the market for only $50. The eXpro X1 has all the same capabilities as the average tablet that sells for $150. It does everything you’d expect like: surfing the net, streaming television and movies, and playing games (of course you can email and social network as well). Front and rear cameras are perfect for taking pictures and video chatting on the 7” LCD touch screen. Games are plentiful as the eXpro X1 runs on Android and comes pre-installed with the GooglePlay app, giving you access to over 1MM apps in the Google Play Store. You can buy tablets for the entire family and differentiate them because they come in nine great color choices. Enjoy family time with your iRulu tablet by accessing the internet via WiFi on 3G networks to stream shows and movies. The tablet connects directly to your television with a standard HDMI cable.
iRULU is a top-selling tablet manufacturer, and has sold over 3MM tablets since 2011. Their products rival the big brands without the big brand price tag. They guarantee your satisfaction and back your purchase with a one year no questions asked warranty. Purchase your tablet today from iRULU.com to save up to 20% and get free shipping!
Bringing the best tips from the experts in Atlanta in business, beauty, wealth management, child healthcare, car shopping, and more. Each year, Atlanta’s Women’s Entrepreneurship Initiative selects 15 local female entrepreneurs for a 15-month business training program. We meet women who have grown their companies, created jobs, and broke through the glass ceiling. With some […]
iMCD is the deadliest subtype of Castleman disease. Approximately one third of patients die within five years of diagnosis, and another third die within 10 years if not treated.
There are no effective treatment options for people with unresectable or metastatic chondrosarcoma despite many attempts by multiple pharmaceutical companies over the past few decades.